These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27369778)

  • 1. Therapeutic Elimination of the Type 1 Interferon Receptor for Treating Psoriatic Skin Inflammation.
    Gui J; Gober M; Yang X; Katlinski KV; Marshall CM; Sharma M; Werth VP; Baker DP; Rui H; Seykora JT; Fuchs SY
    J Invest Dermatol; 2016 Oct; 136(10):1990-2002. PubMed ID: 27369778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury.
    Bhattacharya S; Katlinski KV; Reichert M; Takano S; Brice A; Zhao B; Yu Q; Zheng H; Carbone CJ; Katlinskaya YV; Leu NA; McCorkell KA; Srinivasan S; Girondo M; Rui H; May MJ; Avadhani NG; Rustgi AK; Fuchs SY
    EMBO Mol Med; 2014 Mar; 6(3):384-97. PubMed ID: 24480543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Inhibition of TNFR1 and IFNAR1 in Imiquimod-Induced Psoriasiform Skin Inflammation in Mice.
    Grine L; Dejager L; Libert C; Vandenbroucke RE
    J Immunol; 2015 Jun; 194(11):5094-102. PubMed ID: 25911755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of p38 protein kinase in the ligand-independent ubiquitination and down-regulation of the IFNAR1 chain of type I interferon receptor.
    Bhattacharya S; Qian J; Tzimas C; Baker DP; Koumenis C; Diehl JA; Fuchs SY
    J Biol Chem; 2011 Jun; 286(25):22069-76. PubMed ID: 21540188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the IFNAR1 chain of type 1 interferon receptor in benign cells protects against progression of acute leukemia.
    Zhao B; Bhattacharya S; Yu Q; Fuchs SY
    Leuk Lymphoma; 2018 Jan; 59(1):171-177. PubMed ID: 28503979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-stimulated downregulation of the alpha interferon receptor: role of protein kinase D2.
    Zheng H; Qian J; Varghese B; Baker DP; Fuchs S
    Mol Cell Biol; 2011 Feb; 31(4):710-20. PubMed ID: 21173164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 310 nm UV-LEDs attenuate imiquimod-induced psoriasis-like skin lesions in C57BL/6 mice and inhibit IL-22-induced STAT3 expression in HaCaT cells.
    Kwon TR; Lee SE; Kim JH; Na Jang Y; Kim SY; Mun SK; Kim CW; Na J; Kim BJ
    Photochem Photobiol Sci; 2020 Aug; 19(8):1009-1021. PubMed ID: 32584352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory roles of type I interferon signaling in the lung.
    Feng J; Liu Y; Kim J; Ahangari F; Kaminski N; Bain WG; Jie Z; Dela Cruz CS; Sharma L
    Am J Physiol Lung Cell Mol Physiol; 2024 May; 326(5):L551-L561. PubMed ID: 38375579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-κ Is a Rheostat for Development of Psoriasiform Inflammation.
    Gharaee-Kermani M; Estadt SN; Tsoi LC; Wolf-Fortune SJ; Liu J; Xing X; Theros J; Reed TJ; Lowe L; Gruszka D; Ward NL; Gudjonsson JE; Kahlenberg JM
    J Invest Dermatol; 2022 Jan; 142(1):155-165.e3. PubMed ID: 34364883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible priming phosphorylation promotes ligand-independent degradation of the IFNAR1 chain of type I interferon receptor.
    Bhattacharya S; HuangFu WC; Liu J; Veeranki S; Baker DP; Koumenis C; Diehl JA; Fuchs SY
    J Biol Chem; 2010 Jan; 285(4):2318-25. PubMed ID: 19948722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling.
    Liu J; Carvalho LP; Bhattacharya S; Carbone CJ; Kumar KG; Leu NA; Yau PM; Donald RG; Weiss MJ; Baker DP; McLaughlin KJ; Scott P; Fuchs SY
    Mol Cell Biol; 2009 Dec; 29(24):6401-12. PubMed ID: 19805514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-23/IL-17 immune axis mediates the imiquimod-induced psoriatic inflammation by activating ACT1/TRAF6/TAK1/NF-κB pathway in macrophages and keratinocytes.
    Chen WC; Wen CH; Wang M; Xiao ZD; Zhang ZZ; Wu CL; Wu R
    Kaohsiung J Med Sci; 2023 Aug; 39(8):789-800. PubMed ID: 37098777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the involvement of type I interferon in pulmonary arterial hypertension.
    George PM; Oliver E; Dorfmuller P; Dubois OD; Reed DM; Kirkby NS; Mohamed NA; Perros F; Antigny F; Fadel E; Schreiber BE; Holmes AM; Southwood M; Hagan G; Wort SJ; Bartlett N; Morrell NW; Coghlan JG; Humbert M; Zhao L; Mitchell JA
    Circ Res; 2014 Feb; 114(4):677-88. PubMed ID: 24334027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-193b-3p-ERBB4 axis regulates psoriasis pathogenesis via modulating cellular proliferation and inflammatory-mediator production of keratinocytes.
    Huang C; Zhong W; Ren X; Huang X; Li Z; Chen C; Jiang B; Chen Z; Jian X; Yang L; Liu X; Huang H; Shen C; Chen X; Dou X; Yu B
    Cell Death Dis; 2021 Oct; 12(11):963. PubMed ID: 34667159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3Kδ Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis.
    Mercurio L; Morelli M; Scarponi C; Scaglione GL; Pallotta S; Albanesi C; Madonna S
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unconjugated bilirubin and its derivative ameliorate IMQ-induced psoriasis-like skin inflammation in mice by inhibiting MMP9 and MAPK pathway.
    Bharatha M; Nandana MB; Praveen R; Nayaka S; Velmurugan D; Vishwanath BS; Rajaiah R
    Int Immunopharmacol; 2024 Mar; 130():111679. PubMed ID: 38377853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation.
    Park KD; Kim N; Kang J; Dhakal H; Kim JY; Jang YH; Lee WJ; Lee SJ; Kim SH
    Int Immunopharmacol; 2021 Sep; 98():107883. PubMed ID: 34153674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis.
    Roh YS; Park S; Kim JW; Lim CW; Seki E; Kim B
    Hepatology; 2014 Jul; 60(1):237-49. PubMed ID: 24375615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gomisin M2 alleviates psoriasis‑like skin inflammation by inhibiting inflammatory signaling pathways.
    Kim N; Lee S; Kang J; Kwon TK; Khang D; Kim SH
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34664681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
    Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
    Front Immunol; 2018; 9():79. PubMed ID: 29459858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.